Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients

NCT02556827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2015-09-23

No results posted yet for this study

Summary

Aim of study is to determine reactive oxygen products and antioxidant capacity with rosacea patients; to measure metalloproteinase level and inflammatory markers of immune response and investigate their corelation with demodex infestation and also investigate the role of photoaging and sebum secretion in rosacea.

Conditions

  • Rosacea

Interventions

OTHER

Obtaining a blood sample

Total oxidant capacity (TOC), total antioxidant capacity (TAC), oxidative stress index (OSI), paraoxonase-1 (PON-1), aryl esterase (ARES), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-9 (MMP-9) levels in venous blood were measured.

DEVICE

Reflectance confocal microscopy

1mm2-sized 10 images were taken from right cheek and forehead; the number of demodex, follicle, the number of mite per follicle, the number of infested follicle and the number of mite per infested follicle were calculated with RCM. And photoaging severity were also assessed by using RCM.

DEVICE

Sebumeter

Sebum rate at forehead and right cheek were evaluated with sebumeter

DEVICE

Video dermoscopy

Dermoscopic photoaging scale were assessed by using video dermoscopy.

Sponsors & Collaborators

  • Bezmialem Vakif University

    collaborator OTHER
  • Istanbul Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Tugba Falay · Istanbul Training and Research Hospital

  • Vefa Aslı Erdemir · Istanbul Training and Research Hospital

  • Mehmet Salih Gürel · Istanbul Training and Research Hospital

  • Abdurrahim Kocyigit · Bezmialem Vakif University

  • Duygu Erdil · Istanbul Training and Research Hospital

  • Eray Metin Güler · Bezmialem Vakif University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02556827 on ClinicalTrials.gov